|
|
Biotech
|
|
||
Re: Monday snips$ADMA submits BLA seeking approval for plasma collection facility. Citi raises the PT on $BMRN to $148, keeps a Buy rating $MESO Mesoblast to commence compassionate use of remestemcel-L in COVID-19 patients $EBS Emergent Bio inks five-year deal with J&J for manufacture of COVID-19 vaccine $CYDY CytoDyn inks distribution deal for leronlimab for COVID-19 $AVRO Dosing underway in Avrobio's gaucher disease and cystinosis trials $NVCR Novocure has large growth opportunity in China, says Mizuho |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
33221 | Re: Monday snips/notes | minxmrphd | 9 | 7/6/2020 8:16:19 AM |